A recombinant adenovirus expressing an epstein-barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2394-2402

  Morgan, S M ^a   Wilkinson, G W G ^b   Floettmann, E ^a   Blake, N ^a   Rickinson, A B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ADENOVIRUS; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS RECOMBINANT;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CELL LINE; DNA, VIRAL; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FIBROBLASTS; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029929419     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2394-2402.1996     Document Type: Article

References (43)

1. Bennink, J. R., and J. W. Yewdell. 1988 Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of non-responder MHC class I alleles J. Exp Med. 168:1935-1939.
2. Boon, T., J.-C. Cerottini, B. Van den Eynde, P. Van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognised by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
3. Borysiewicz, L. K., A. Fiander, M. Nimako, S. Man, G. W. G. Wilkinson, A. S. Evans, M. Adams, S. N. Stacey, M. E. G. Boursnell, E. Rutherford, J. K. Hickling, and S. C. Inglis. The use of a recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as an immunotherapy for cervical cancer patients. Submitted for publication.
4. Borysiewicz, L. K., J. K. Hickling, S. Graham, J. Sinclair, M. P. Cranage, G. L. Smith, and J. G. P. Sissons. 1988. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognising the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J. Exp. Med 168:919-931.
5. Brooks, J. M., R. J. Murray, W. A. Thomas, M. G. Kurilla, and A. B. Rickinson. 1993. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 178:879-887.
6. Burrows, S. R., I. S. Misko, T. B. Sculley, D. Schmidt, and D. J. Moss. 1990. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants. J Virol. 64:3974-3976.
7. Burrows, S. R., A. Suhrbier, R. Khanna, and D. J. Moss. 1992. Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. Immunology 76:174-175.
8. DiBrino, M., K. C. Parker, D. H. Margulies, J. Shiloach, R. V. Turner, W. E. Biddison, and J. E. Coligan. 1995. Identification of the peptide binding motif for HLA-B44. one of the most common HLA-B alleles in the Caucasian population Biochemistry 34:10130-10138.
9. Doumas, B. T. 1975. Standards for total serum protein assays - a collaborative study Clin. Chem 21:1159-1166.
10. Fooks, A. R., E. Schadeck, U. G. Liebert, A. B. Dowsett, B. K. Rima, M. Steward, J. R. Stephenson, and G. W. G. Wilkinson. 1995. High level expression of the measles nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210:456-460.
11. Gavioli, R., M. G. Kurilla, P. O. de Campos-Lima, L. E. Wallace, R. Dolcetti, R. J. Murray, A. B. Rickinson, and M. G. Masucci. 1993. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J. Virol. 67:1572-1578.
12. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-299.
13. Graham, F. L., and L. Prevec. 1991. Manipulation of adenovirus vectors, p. 109-128. In E. J Murray (ed.), Methods in molecular biology. Humana Press, Clifton, N.J.
14. Haddada, H., M. Lopez, C. Martinache, T. Ragot, M. A. Abina, and M. Perricaudet. 1993. Efficient adenovirus mediated gene transfer into human blood monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 195:1174-1183.
15. Hanke, T., F. L. Graham, K. L. Rosenthal, and D. C. Johnson. 1991. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65:1177-1186.
16. Hill, A. B., S. P. Lee, J. S. Haurum, N. Murray, Q. Y. Yao, M. Rowe, N. Signoret, A. B. Rickinson, and A. J. McMichael. 1995. Class I major histocompatibility complex-restricted cytutoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid lines against which they were raised. J. Exp. Med. 181: 2221-2228.
17. Hill, A. B., A. Worth, T. Elliott, S. Rowland-Jones, J. M. Brooks, A. B. Rickinson, and A. J. McMichael. 1995. Characterisation of two Epstein-Barr virus epitopes restricted by HLA-B7. Eur. J. Immunol. 25:18-24.
18. Horvath, J., and J. M. Weber. 1988. Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection. J. Virol. 62:341-345.
19. Huang, S., R. I. Endo, and G. R. Nemerow. 1995. Upregulation of integrins αvβ3 and αvβ5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69:2257-2263.
20. Jacobs, S. C., J. R. Stephenson, and G. W. G. Wilkinson. 1992. High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector, protection elicited in a murine model. J. Virol. 66: 2086-2095.
21. Jacobs, S. C., J. R. Stephenson, and G. W. G. Wilkinson. 1994. Protection elicited by a replication defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. J. Gen. Virol. 75:2399-2402.
22. Khanna, R., S. R. Burrows, M. G. Kurilla, C. A. Jacob, I. S. Misko, T. B. Sculley, E. Kieff, and D. J. Moss. 1992. Localisation of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176:169-178.
23. Khanna, R., C. A. Jacob, S. R. Burrows, M. G. Kurilla, E. Kieff, I. S. Misko, T. B. Sculley, and D. J. Moss. 1991. Expression of Epstein-Barr virus nuclear antigens in anti-IgM stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cells. Immunology 74: 504-510.
24. Lee, S. P., W. A. Thomas, R. J. Murray, F. Khanim, S. Kaur, L. S. Young, M. Rowe, M. Kurilla, and A. B. Rickinson. 1993. HLA A2 1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol. 67:7428-7435.
25. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen 1. Nature (London) 375:685-688.
26. Maunders, M. J., L. Petti, and M. Rowe. 1994. Precipitation of the Epstein-Barr virus protein EBNA2 by an EBNA3c-specific monoclonal antibody. J Gen. Virol. 75:769-778
27. McFadden, G., and K. Kane. 1994. How DNA viruses perturb functional MHC expression to alter immune recognition. Adv Cancer Res 63:117-209.
28. McGrory, W. J., D. S. Bautista, and F. L. Graham. 1988. A simple technique for the rescue of early region 1 mutants into infectious adenovirus type 5. Virology 163:614-617.
29. McLaughlin-Taylor, E., H. Pande, S. J. Forman, B. Tanamanchi, C. R. Li, J. A. Zaia, P. D. Greenberg, and S. R. Riddell. 1994 Identification of the major late cytomegalovirus protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J. Med. Virol 43:103-110.
30. Melief, C. J. M., and W. M. Kast. 1993. Potential immunogenicity of oncogene and tumour suppressor gene products. Curr. Opin. Immunol 5:709-713
31. Moss, D. J., I. S. Misko, S. R. Burrows, K. Burman, R. McCarthy, and T. B. Sculley. 1988. Cytotoxic T cell clones discriminate between A and B type Epstein-Barr virus transformants. Nature (London) 331:719-721
32. Moss, D. J., I. S. Misko, T. B. Sculley, A. Apolloni, R. Khanna, and S. R. Burrows. 1991. Immune regulation of Epstein-Barr virus (EBV) - EBV nuclear antigen as a target for EBV-specific T-cell lysis Semin. Immunopathol 13:147-156.
33. Murray, R. J., M. G. Kurilla, J. M. Brooks, W. A. Thomas, M. Rowe, E. Kieff, and A. B. Rickinson. 1992. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies J Exp. Med 176:157-168.
34. Petti, L., J. Sample, F. Wang, and E. Kieff. 1988. A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. J. Virol. 62:1330-1338.
35. Rabin, H., R. F. Hopkins, F. W. Ruscetti, R. H. Neubauer, R. L. Brown, and T. G. Kawakami. 1981. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumour cells J. Immunol. 127:1852-1856.
36. Ressing, M. E., A. Sette, R. M. P. Brandt, J. Ruppert, P. A. Wentworth, M. Hartman, C. Oseroff, H. M. Grey, C. J. M. Melief, and W. M. Kast. 1995 Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A0201-binding peptides J. Immunol. 154:5934-5943.
37. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus, p. 2397-2446. In B. N. Fields, D. M Knipe, and P. M. Howley (ed), Virology. Lippincott-Raven Publishers, Philadelphia.
38. Spessot, R., T. M. Inchley, T. M. Hupel, and S. Bacchetti. 1989 Cloning of herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. Virology 168:378-387.
39. Townsend, A., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601-624.
40. Wallace, L. E., M. Rowe, J. S. H. Gaston, A. B. Rickinson, and M. A. Epstein. 1982. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2 Eur. J Immunol. 12:1012-1018
41. Wilkinson, G. W. G., and A. Akrigg. 1992. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector Nucleic Acids Res. 20:2233-2239.
42. York, I. A., C. Roop, D. W. Andrews, S. Riddell, F. Graham, and D. C. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes Cell 77:525-535.
43. zur Hausen, H. 1991 Human papillomaviruses in the pathogenesis of anogenital cancer Virology 184:9-13.